[go: up one dir, main page]

FI962952L - Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset - Google Patents

Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset Download PDF

Info

Publication number
FI962952L
FI962952L FI962952A FI962952A FI962952L FI 962952 L FI962952 L FI 962952L FI 962952 A FI962952 A FI 962952A FI 962952 A FI962952 A FI 962952A FI 962952 L FI962952 L FI 962952L
Authority
FI
Finland
Prior art keywords
delta
iso
pharmaceutical compositions
compositions containing
taxol analogues
Prior art date
Application number
FI962952A
Other languages
English (en)
Swedish (sv)
Other versions
FI962952A0 (fi
Inventor
Robert C Kelly
Peter G M Wuts
Nancy Anne Wicnienski
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI962952A0 publication Critical patent/FI962952A0/fi
Publication of FI962952L publication Critical patent/FI962952L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI962952A 1994-01-28 1996-07-24 Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset FI962952L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18923594A 1994-01-28 1994-01-28
PCT/US1995/000551 WO1995020582A1 (en) 1994-01-28 1995-01-26 Δ12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
FI962952A0 FI962952A0 (fi) 1996-07-24
FI962952L true FI962952L (fi) 1996-07-24

Family

ID=22696514

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962952A FI962952L (fi) 1994-01-28 1996-07-24 Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset

Country Status (28)

Country Link
US (1) US5821363A (fi)
EP (1) EP0741716B1 (fi)
JP (1) JPH09508385A (fi)
KR (1) KR100378972B1 (fi)
CN (1) CN1163492C (fi)
AT (1) ATE221059T1 (fi)
AU (1) AU691575B2 (fi)
CA (1) CA2179176A1 (fi)
CZ (1) CZ208996A3 (fi)
DE (1) DE69527506T2 (fi)
DK (1) DK0741716T3 (fi)
ES (1) ES2181766T3 (fi)
FI (1) FI962952L (fi)
HU (1) HUT74508A (fi)
IL (7) IL112412A (fi)
LV (1) LV13120B (fi)
MX (1) MX9603052A (fi)
MY (1) MY130544A (fi)
NO (1) NO317832B1 (fi)
NZ (2) NZ279625A (fi)
PL (1) PL187409B1 (fi)
PT (1) PT741716E (fi)
RU (1) RU2142950C1 (fi)
SI (1) SI0741716T1 (fi)
SK (1) SK283780B6 (fi)
TW (1) TW464645B (fi)
WO (1) WO1995020582A1 (fi)
ZA (1) ZA95668B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
FR2742754B1 (fr) * 1995-12-22 1998-01-16 Rhone Poulenc Rorer Sa Procede de preparation de taxoides
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
WO1996000724A1 (en) * 1994-06-28 1996-01-11 Pharmacia & Upjohn Company 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
WO1996014309A1 (en) * 1994-11-04 1996-05-17 Pharmacia & Upjohn S.P.A Taxane derivatives
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
CA2170661A1 (en) 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
FR2743074B1 (fr) 1995-12-27 1998-03-27 Seripharm Procede de protection selective des derives de la baccatine et son utilisation dans la synthese des taxanes
US5696152A (en) * 1996-05-07 1997-12-09 Wisconsin Alumni Research Foundation Taxol composition for use as organ preservation and cardioplegic agents
DE69731005T2 (de) * 1996-05-08 2005-10-06 Pharmacia & Upjohn Co., Kalamazoo Verfahren zu Herstellung von Taxol
US5902822A (en) * 1997-02-28 1999-05-11 Bristol-Myers Squibb Company 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
EP2292225B9 (en) 1997-03-31 2012-06-27 Boston Scientific Scimed Limited Dosage form comprising taxol in crystalline form
US8791081B2 (en) * 1999-08-13 2014-07-29 Case Western Reserve University MGMT inhibitor combination for the treatment of neoplastic disorders
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
DE60131537T2 (de) 2000-06-22 2008-10-23 Nitromed, Inc., Lexington Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung
EP1351681B1 (en) * 2001-01-16 2010-09-15 Vascular Therapies, LLC Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
AU2003273671A1 (en) * 2002-10-09 2004-05-04 Phytogen Life Sciences, Inc. Novel taxanes and methods related to use and preparation thereof
FR2853651B1 (fr) * 2003-04-14 2005-05-20 Aventis Pharma Sa Procede de preparation du 4,10 beta-diacetoxy-2 alpha- benzoyloxy-5 beta, 20-epoxy-1, 13 alpha-dihydroxy-9-oxo-19- norcyclopropa[g]tax-11-ene
US6956124B2 (en) 2003-04-14 2005-10-18 Aventis Pharma S.A. Process for the preparation of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-19-norcyclopropa[g]tax-11-ene
WO2007024678A2 (en) * 2005-08-19 2007-03-01 Bristol-Myers Squibb Company Scintillation proximity assay for the identification of p-glycoprotein modulators
EP2557087A1 (en) * 2006-10-19 2013-02-13 Monell Chemical Senses Center Human salty taste receptor and methods of modulating salty taste perception
CN101468974B (zh) * 2007-12-28 2011-02-09 上海百灵医药科技有限公司 多烯紫杉醇的半合成方法
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
CN104109142A (zh) * 2014-06-22 2014-10-22 南京工业大学 一种以巴卡丁iii为原料制备卡巴他赛的方法
CN108976217B (zh) * 2018-09-11 2021-03-26 济南爱思医药科技有限公司 一种多西他赛-1,2,3,-三氮唑化合物及其合成工艺和应用
CN115260130A (zh) * 2022-07-07 2022-11-01 上海卓鼎生物技术有限公司 一种10-脱乙酰基紫杉醇的制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601676B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4876399A (en) * 1987-11-02 1989-10-24 Research Corporation Technologies, Inc. Taxols, their preparation and intermediates thereof
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
US5157049A (en) * 1988-03-07 1992-10-20 The United States Of America As Represented By The Department Of Health & Human Services Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
EP0366841A1 (en) * 1988-11-03 1990-05-09 Dresser-Rand Company A crosshead and crosshead pin coupling arrangement
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
CA2023645C (fr) * 1989-08-23 2002-03-26 Jean-Noel Denis Procede pour la preparation enantioselective de derives de la phenylisoserine
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
FR2658513B1 (fr) * 1990-02-21 1994-02-04 Rhone Poulenc Sante Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r).
FR2658510B1 (fr) * 1990-02-21 1992-04-30 Rhone Poulenc Sante Nouveau derive de la beta-phenylisoserine, sa preparation et son emploi.
FR2662440B1 (fr) * 1990-05-22 1992-07-31 Rhone Poulenc Sante Procede de preparation stereoselective de derives de la phenylisoserine.
FR2662441B1 (fr) * 1990-05-22 1992-10-23 Rhone Poulenc Sante Procede de preparation enantioselective de derives de la phenylisoserine.
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2679230B1 (fr) * 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
FR2687151B1 (fr) * 1992-02-07 1994-03-25 Rhone Poulenc Rorer Sa Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5248796A (en) * 1992-06-18 1993-09-28 Bristol-Myers Squibb Company Taxol derivatives
ATE136460T1 (de) * 1992-07-01 1996-04-15 Bristol Myers Squibb Co Fluor-taxole mit antitumor-wirkung
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
FR2696458B1 (fr) * 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696464B1 (fr) * 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2697522B1 (fr) * 1992-10-30 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5380751A (en) * 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
CA2109861C (en) * 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
PL315576A1 (en) 1996-11-12
CN1139925A (zh) 1997-01-08
US5821363A (en) 1998-10-13
WO1995020582A1 (en) 1995-08-03
TW464645B (en) 2001-11-21
DE69527506D1 (de) 2002-08-29
NO963133L (no) 1996-09-13
MY130544A (en) 2007-06-29
PL187409B1 (pl) 2004-07-30
IL127592A0 (en) 1999-10-28
HUT74508A (en) 1997-01-28
IL127597A0 (en) 1999-10-28
AU691575B2 (en) 1998-05-21
AU1680695A (en) 1995-08-15
LV13120B (en) 2004-03-20
ATE221059T1 (de) 2002-08-15
HU9602051D0 (en) 1996-09-30
IL127598A0 (en) 1999-10-28
CN1163492C (zh) 2004-08-25
EP0741716A1 (en) 1996-11-13
NO317832B1 (no) 2004-12-20
CA2179176A1 (en) 1995-08-03
DE69527506T2 (de) 2003-03-20
NO963133D0 (no) 1996-07-26
ZA95668B (en) 1996-07-29
SK90296A3 (en) 1998-03-04
IL112412A0 (en) 1995-03-30
RU2142950C1 (ru) 1999-12-20
CZ208996A3 (en) 1996-11-13
JPH09508385A (ja) 1997-08-26
ES2181766T3 (es) 2003-03-01
IL127599A (en) 2004-06-01
KR100378972B1 (ko) 2003-06-19
SK283780B6 (en) 2004-01-08
NZ331211A (en) 2000-03-27
DK0741716T3 (da) 2002-11-18
IL127597A (en) 2003-07-31
IL127598A (en) 2003-04-10
FI962952A0 (fi) 1996-07-24
NZ279625A (en) 1998-10-28
SI0741716T1 (en) 2002-12-31
MX9603052A (es) 1997-06-28
IL112412A (en) 2000-02-29
EP0741716B1 (en) 2002-07-24
PT741716E (pt) 2002-12-31

Similar Documents

Publication Publication Date Title
FI962952L (fi) Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
FI952920L (fi) 7-halogeeni- ja 7beta,8beta-metano-taksolit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
IL117962A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
IL106927A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
HUP9700709A3 (en) 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds
IL135176A0 (en) Benzothiazole derivatives and pharmaceutical compositions containing the same
IL102616A0 (en) 1,3-oxathiolane nucleoside analogues,methods for the preparation thereof and pharmaceutical compositions containing the same
IL143799A0 (en) Phenoxyphenyl derivatives and pharmaceutical compositions containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
HUP9800792A3 (en) Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same
IL136941A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
IL136940A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
FI972309A0 (fi) 2-heterosyklyylioksi- ja tiometyyli-1,2,5-tiaditsolidin-3-oni-1,1-dioksideja, niitä sisältäviä koostumuksia ja menetelmä niiden valmistamiseksi
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
IL135366A0 (en) Substituted benzoxazoles and pharmaceutical compositions containing the same
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
IL114670A0 (en) Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
FI943688L (fi) Uudet 11-bentsaldoksiimi-17beta-metoksi-27alfa-metoksi-metyyli-estradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä sisältävät lääkeaineet
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
FI951789L (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
FI943645L (fi) Uusia bakkatiini-III ja 10-deasetyylibakkatiini-III-johdannaisia, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia